Advances in autologous stem cell and biomaterial engineering are transforming the future of regenerative medicine by enabling scalable, patient-derived therapies.
- CGT Manufacturing Shifts From Capacity To Strategy
- Rethinking CQV In A Digital, Agile Manufacturing Landscape
- Will FDA's One-Day Inspection Pilot Stand The Test Of Time?
- The Next Frontier In Women's Cancer Care: Combining Cell Therapy With Immuno-Oncology
- Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease
- A Multi-Agent Audit Intelligence Framework For CDMO Quality Oversight
- Why Contamination Control By Design Should Matter To Your CDMO
- Repeating Sanofi's Ballroom Design On Two Continents
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1220382102-lab-research]( "A Scalable Platform To Revolutionize Gene Therapy Manufacturing")
A Scalable Platform To Revolutionize Gene Therapy ManufacturingDiscover how our innovative rAAV production platform can revolutionize your gene therapy pipeline with unparalleled yield, quality, and scalability.
-
![GettyImages-1354923731-magnifying-glass-mrna]( "Best Practices For Analysis Of In Vitro Transcribed (IVT) mRNA")
Best Practices For Analysis Of In Vitro Transcribed (IVT) mRNALearn best practices for high-resolution analysis of IVT RNA using automated capillary electrophoresis. Improve accuracy and precision in quantifying critical quality attributes.
-
![GettyImages-1312272657 patient advocacy centricity]( "How Patient-Centric Approaches Are Shaping The Future Of CGT")
How Patient-Centric Approaches Are Shaping The Future Of CGTEmily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.
-
![GettyImages-1309776439-scientists-lab-analysis-manufacturing]( "Optimized Transient Transfection Platform: AAV Program From Gene To GMP")
Optimized Transient Transfection Platform: AAV Program From Gene To GMPAchieve faster AAV gene therapy progress by adopting a unified platform for manufacturing. Accelerate your program to GMP readiness with up to 9x higher titers and robust, high-quality full capsid yields.
-
![Commercial strategy_GettyImages-1461608537]( "Scaling Manufacturing For Global Success")
Scaling Manufacturing For Global SuccessThis collaboration demonstrates how a partnership-driven approach, combined with technical expertise, can deliver scalable, efficient, and reliable manufacturing solutions that support successful global commercialization.
-
![GettyImages-2189138619 lab]( "The Effect Of Mixing Homogeneity In Retentate Vessel")
The Effect Of Mixing Homogeneity In Retentate VesselDiscover a novel analytical method enhancing TFF diafiltration insights that deliver superior mixing, reliable scale-up, and breakthrough interpretation of diavolume performance.
-
![Scientist Research Data GettyImages-1140779713]( "Simplified Workflow Using Automated Instrument Setup And Compensation On The BD FACSLyric™ Flow Cytometer")
Simplified Workflow Using Automated Instrument Setup And Compensation On The BD FACSLyric™ Flow CytometerExamine the usability and performance capabilities of a system that provides a streamlined flow cytometry workflow, from instrument initialization to data acquisition and analysis.
-
![Lipid Nanoparticles GettyImages-1437855772]( "How Lipid Nanoparticles Enable Next-Gen Delivery")
How Lipid Nanoparticles Enable Next-Gen DeliveryCell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
![GettyImages-1069264194-syringe-filter-vial-lab]( "Protect Your Columns And Your Peaks")
Protect Your Columns And Your PeaksLearn how thoughtful filter selection can protect LC systems, improve protein recovery, and support reliable chromatographic results with key performance data and solvent compatibility insights.
-
![SUS - Image_Case_study_automating_450x300]( "Automating The Process Of Filling Media Into Bottles")
Automating The Process Of Filling Media Into BottlesLearn how a vaccine manufacturer using a wide range of containers for media and buffer filling was able to increase efficiency by 70% with an automated closed-system solution.
NEWSLETTER ARCHIVE
- 05.28.26 -- Accelerate Your Assay And Imaging Data With These New Tools
- 05.28.26 -- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- 05.27.26 -- Smarter Processing For Workflows From Discovery To Commercial Scale
- 05.27.26 -- Rethinking Sterile Welding In Bioprocessing
- 05.27.26 -- Bridging Analytical Gaps To Ensure CGT Material Quality
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
- Regeneron Advances In Vivo Gene Therapy For Hearing Loss
- Sana, Mayo Clinic Advance A New Model For Cell Therapy Delivery In T1D
- Reprogramming T-Cell Access To Solid Tumors Through Improved Trafficking And Entry
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
